The human cost of Herceptin - how other cancer patients pay the price

Doctors have calculated that their trust will have to cut £2.3 million from cancer services to implement NICE guidance on Herceptin.

Herceptin
Herceptin

New guidance from NICE recommends trastuzumab (Herceptin) in early breast cancer but provides no extra funding.

Doctors at the Norfolk and Norwich University Hospital NHS Trust and the University of East Anglia said they would have to find £1.9 million a year to make Herceptin available to the patients who may be eligible. This becomes £2.3 million when the costs of testing and monitoring patients are added.

After auditing drug costs in their hospital’s cancer centre, they estimated that they could save £1.9 million by cutting chemotherapy and palliative care treatments.

This would enable them to treat 75 patients with Herceptin, but they would have to stop 355 patients receiving adjuvant treatment (16 of whom would be cured) or 208 patients receiving palliative chemotherapy.

Writing in the BMJ, the doctors argue that NICE should be given responsibility to decide what to cut to fund newly recommended technologies, or have the ability to allocate extra funds, rather than leaving rationing decisions to medical staff.

MIMS link

Cancer

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Medical examiners to scrutinise deaths in community settings

The MDU's Dr Kathryn Leask explains how the expansion of the medical examiner system...

Person receiving a COVID-19 booster

COVID-19 booster campaign to start on 5 September, NHS England says

The COVID-19 booster programme will begin in care homes and for housebound patients...

GP consulting room

Nine in ten GPs fear their practice will struggle to cope this winter

Nearly nine in ten GPs fear that their practice will struggle to cope this winter,...

BMA sign

BMA elects new deputy chair of England GP committee and chair of Scottish council

Dr David Wrigley has been elected as new deputy chair of the BMA's GP committee in...

UK money

Almost half of practices say income from private fees has fallen in past year

Almost half of GP practices have seen their income from private and professional...

COVID-19 vaccination centre

BMA raises 'serious concerns' about GP workload and funding for autumn COVID boosters

The BMA has raised 'serious concerns' about the workload implications of this autumn's...